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Over the past several years, the prevalence of human 
disease  caused  by  nontuberculous  mycobacteria  (NTM) 
has increased. Whether the increase in cases is real or 
whether more cases are being recognized remains unclear. 
Despite a considerable increase in knowledge about NTM 
infections, they still represent a diagnostic and therapeutic 
challenge for several reasons: 1) pathogenic isolates may 
be indistinguishable from contaminant or saprophytic iso-
lates; 2) timely and reliable identification of isolates may 
depend on proper communication between clinicians and 
laboratory staff; 3) lack of standardized susceptibility test-
ing makes adoption of tailored therapies unrealistic; and 4) 
lack of treatment guidelines exposes patients to toxic drugs 
and disappointing outcomes. Laboratory research and mul-
ticenter controlled trials are needed to improve diagnosis 
and treatment of these infections.
T
he >120 recognized species of nontuberculous myco-
bacteria (NTM) share common features: 1) they are 
facultative  pathogens;  2)  evidence  of  human-to-human 
transmission is lacking; 3) some NTM species are ubiqui-
tous and others have more restricted distribution; 4) treat-
ment may be difficult and vary according to the involved 
organism and disease site; and 5) pathogenesis is still un-
defined, depending on the interaction between the micro-
organism and the host’s immune system (1). About 90% 
of cases involve the pulmonary system; the rest involve 
lymph nodes, skin, soft tissues, and bones. Less frequently 
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Learning Objectives
Upon completion of this activity, participants will be able to:
Diagnose and treat nontuberculous mycobacterial (NTM) lymphadenitis effectively •	
Identify elements of NTM osteoarticular infections •	
Treat NTM skin infections according to standards of care •	
Describe infections with rapidly growing mycobacteria •	
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CME Questions
Activity Evaluation
1. Which of the following statements about nontuberculous 








2. Which of the following statements about osteoarticular 









3. Which of the following treatments is appropriately matched 








4. Which of the following statements about rapidly growing 
mycobacteria (RGM) is most accurate?
A.		 They	respond	to	sterilization	with	formaldehyde	solutions	
only





1. The activity supported the learning objectives. 
Strongly	Disagree Strongly	Agree	
1 2 3 4 5
2. The material was organized clearly for learning to occur.
Strongly	Disagree Strongly	Agree
1 2 3 4 5
3. The content learned from this activity will impact my practice.
Strongly	Disagree Strongly	Agree
1 2 3 4 5
4. The activity was presented objectively and free of commercial bias.
Strongly	Disagree Strongly	Agree
1 2 3 4 5
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